Newswise — NEW YORK CITY, May 8, 2020 — Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments for staff with Chair- and Chief-level positions:
Tsvi Gal Is Named MSK’s Head of Infrastructure
Tsvi Gal has been appointed Head of Infrastructure of MSK. Mr. Gal assumed his role on April 28. Mr. Gal will lead the hospital’s technological and architectural development and make technical recommendations that align with MSK’s institutional and digital priorities.
Reporting to MSK’s Chief Information Officer, Atefeh Riazi, Mr. Gal will work with other leaders in Digital Informatics and Technology Solutions to develop a modernized infrastructure and data environment in support of MSK’s digital strategy, set by MSK’s Chief Digital Officer Claus Jensen.
Marcel van den Brink Is Elected to Royal Netherlands Academy of Arts and Sciences
Marcel R. M. van den Brink, MD, PhD, Head of the Division of Hematologic Malignancies and Alan N. Houghton Chair, has been elected to the Royal Netherlands Academy of Arts and Sciences (Koninklijke Nederlandse Akademie van Wetenschappen, or KNAW). Dr. van den Brink is one of 18 new members to be elected to KNAW. Members consist of leading scientists across all disciplines and are chosen for their scientific achievements.
Scott Keeney and Christopher Lima Are Elected to National Academy of Sciences
Scott Keeney, PhD, a member of the Molecular Biology Program at Sloan Kettering Institute (SKI) and an Investigator of the Howard Hughes Medical Institute, and Christopher Lima, PhD, Chair of SKI’s Structural Biology Program and an Investigator of the Howard Hughes Medical Institute, have been elected to the National Academy of Sciences.
Dr. Keeney is being recognized for his quest to understand the mechanism of meiotic recombination and to determine how this process is coordinated with other events of meiotic prophase.
Dr. Lima is being recognized for his work on the structural, biochemical, and functional characterization of macromolecules involved in post-translational protein modification by ubiquitin and ubiquitin-like proteins such as SUMO, and the pathways that contribute to co- and post-transcriptional RNA maturation, processing, and decay.
Stuart Lichtman and Mark Robson Are Named 2020 Fellows of the American Society of Clinical Oncology
Stuart Lichtman, MD, FACP, FASCO, medical oncologist, and Mark Robson, MD, Chief of the Breast Medicine Service, were named a recipients of the Fellow of the American Society of Clinical Oncology (FASCO) distinction from the ASCO Special Awards. The FASCO recognizes ASCO members for their contributions to cancer care as well as their extraordinary volunteer service, dedication, and commitment to the Society.
Mithat Gönen Is Elected President-Elect to the Society for Clinical Trial’s Board of Directors
Mithat Gönen, PhD, Chief of the Biostatistics Service, was elected as President-Elect to the Board of Directors of the Society for Clinical Trials, a multidisciplinary society focusing on the methodology and conduct of clinical trials with membership spanning many disciplines including biostatistics, clinical areas, information technology and systems, data management, ethics, regulatory bodies, behavioral science, research coordination, patient partners, health outcomes research.
He will be President-Elect from May 2020 to May 2021; President from May 2021 to May 2022; and Past-President from May 2022 to May 2023. In this role, Dr. Gönen will be responsible for all aspects and decision-making involving the daily operations, short-term planning of activities and long-term strategic planning of the society.
David Klimstra Is Elected President of Pancreatobiliary Pathology Society
David Klimstra, MD, Chair of the Department of Pathology and James Ewing Alumni Chair of Pathology, was elected President of the Pancreatobiliary Pathology Society at the 2020 United States and Canadian Academy of Pathology Annual Meeting in February.
Laura Cerviño Is Named 2020 Fellow of American Association of Physicists in Medicine
Laura Cerviño, PhD, Chief of the Radiotherapy Physics Service, was named a 2020 American Association of Physicists in Medicine (AAPM) Fellow. Dr. Cerviño was recognized for her contributions in medicine.
She will be recognized at the upcoming joint AAPM/Canadian Organization of Medical Physicists virtual meeting in Vancouver on July 13, 2020.
About Memorial Sloan Kettering (MSK):
As the world’s oldest and largest private cancer center, Memorial Sloan Kettering has devoted more than 135 years to exceptional patient care, influential educational programs and innovative research to discover more effective strategies to prevent, control and, ultimately, cure cancer. MSK is home to more than 20,000 physicians, scientists, nurses and staff united by a relentless dedication to conquering cancer. Today, we are one of 51 National Cancer Institute-designated Comprehensive Cancer Centers, with state-of-the-art science and technology supporting groundbreaking clinical studies, personalized treatment, and compassionate care for our patients. We also train the next generation of clinical and scientific leaders in oncology through our continually evolving educational programs, here and around the world. Year after year, we are ranked among the top two cancer hospitals in the country, consistently recognized for our expertise in adult and pediatric oncology specialties. www.mskcc.org.